by Eric Christianson | Sep 16, 2020 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
GLP-1 agonists are an effective medication in treating type 2 diabetes mellitus. GLP-1 agonists are a synthetic version of the body’s naturally occurring GLP-1. However, synthetic GLP-1 has the advantage of being resistant to DPP4 degradation. GLP-1 agonists have...
by Eric Christianson | Sep 13, 2020 | Drug Interaction Case Studies and Education For Pharmacists
PPIs are well known for their ability to block the release of hydrogen ions into the gut. Because of this, the use of PPIs can lead to a basic environment in the stomach. This is synonymous to have an elevated pH in the stomach. Some oral medications can be...
by Eric Christianson | Sep 9, 2020 | Drug Interaction Case Studies and Education For Pharmacists
When most healthcare professionals think about drug interactions, we tend to think about an issue arising when a medication is added to the regimen. A perfect example is the warfarin Bactrim interaction. Here’s a case scenario involving cholestyramine and...
by Eric Christianson | Sep 6, 2020 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Parkinson’s disease can be very debilitating and not understanding how medications should be dosed can compound the problem. Let’s review the pharmacology briefly and why you need to be careful with Sinemet 10/100. In Parkinson’s, we have a dopamine...
by Eric Christianson | Sep 2, 2020 | Drug Interaction Case Studies and Education For Pharmacists
Drug food interactions are common and there can be significant negative consequences from these interactions. A common misconception amongst healthcare professionals who may not have as much experience with drug interactions is that ALL statins interact with...
